Comparison of Etest, agar dilution, broth microdilution and disk diffusion methods for testing in vitro activity of levofloxacin against Staphylococcus spp. isolated from neutropenic cancer patients

International Journal of Antimicrobial Agents

Volumn 19, Issue 2, 2002, Pages 147-154

  Di Bonaventura, Giovanni ^a   D'Antonio, Domenico ^b   Catamo, Giovanni ^a   Ballone, Enzo ^a   Piccolomini, Raffaele ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b SPIRITO SANTO HOSPITAL   (Italy)

Author keywords

Etest; Levofloxacin; Neutropenic patients; Staphylococcus spp.; Susceptibility testing

Indexed keywords

LEVOFLOXACIN;

AGAR GEL DIFFUSION; ANALYTICAL ERROR; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DIAGNOSTIC ACCURACY; DILUTION; HUMAN; IN VITRO STUDY; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NEUTROPENIA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; TECHNIQUE;

AGAR; ANTI-INFECTIVE AGENTS; CULTURE MEDIA; DIFFUSION; DRUG RESISTANCE, MICROBIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NEOPLASMS; NEUTROPENIA; OFLOXACIN; STAPHYLOCOCCUS;

EID: 0036180408     PISSN: 09248579     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0924-8579(01)00483-6     Document Type: Article

References (28)

1. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients
2. Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with hematological malignancies
3. The impact of rufloxacin given as prophylaxis to patients with cancer on their oral and faecal microflora
4. Intravenous ciprofloxacin for infections in cancer patients
5. The changing epidemiology of infections at cancer hospitals
6. Epidemiology of quinolone resistance: Europe and North and South America
7. In vitro and in vivo antibacterial activities of levofloxacin (L-ofloxacin), an optically active ofloxacin
8. In vitro and in vivo activity of DR-3355, an optically active isomer of ofloxacin
9. Levofloxacin in vitro activity: results from an international comparative study with ofloxacin and ciprofloxacin
10. Comparative in vitro activity of levofloxacin and ofloxacin against Gram-positive bacteria
11. In vitro activity of levofloxacin against Gram-positive bacteria
12. Management of fever in patients with cancer and treatment-induced neutropenia
13. Predominance of Gram-positive microorganisms as a cause of septicemia in patients with hematological malignancies
14. Comparison of the Etest with agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria
15. Evaluation of the E-test, a novel method of quantifying antimicrobial activity
16. Evaluation of the Etest for antimicrobial susceptibility testing of Pseudomonas aeruginosa isolates from long-term bladder catheterized patients
17. Comparison of the Etest to agar dilution and broth microdilution methods for quantitative antimicrobial susceptibility testing of Helicobacter pylori
18. Antimicrobial susceptibility testing: general principles and contemporary practices
19. Susceptibilities of bacterial isolates from patients with cancer to levofloxacin and other quinolones
20. Susceptibility to levofloxacin of clinical isolates of bacteria from intensive care and hematology/oncology patients in Switzerland: a multicentre study
21. In vitro activity of trovafloxacin against clinical bacterial isolates from patients with cancer
22. Antimicrobial activity of gatifloxacin compared to seven other compounds tested against Gram-positive organisms isolated at 10 cancer-treatment centers
23. Critical appraisal of Etest for the detection of fluoroquinolone resistance
24. The importance of in-vitro susceptibility testing in the management of compromised hosts